Table 3 Point prevalence study: most frequent combinations of sedative and analgesic agents and single sedative/analgesic agents
From: National survey and point prevalence study of sedation practice in UK critical care
Sedative/analgesic agents | n (%) |
|---|---|
Most frequenta combinations of sedative and analgesicb agents | |
Propofol and alfentanil | 49 (20.3) |
Propofol and fentanyl | 44 (18.2) |
Propofol and remifentanil | 12 (5.0) |
Propofol and morphine | 10 (4.1) |
Propofol, midazolam and alfentanil | 4 (1.7) |
Propofol, midazolam and fentanyl | 4 (1.7) |
Propofol, clonidine and alfentanil | 3 (1.2) |
Most frequenta single sedative agents | |
Propofol | 15 (6.2) |
Clonidine | 5 (2.1) |
Most frequenta single analgesicb agents | |
Morphine | 22 (9.1) |
Fentanyl | 8 (3.3) |
Alfentanil | 5 (2.1) |
Remifentanil | 4 (1.7) |